ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2360

Perceptions of Patients with Rheumatoid Arthritis about Self-Assessment of Disease Activity after Watching an Educational Video: Qualitative Pilot Results from the Auto-DAS in Middle Eastern Arab Countries Study

Nelly Ziade1, Sahar Saad2, Manal al Mashaleh3, Lina el Kibbi4, Bassel el Zorkany5, Humeira Badsha6, Ghita Harifi6, Amani Daher7, Nelly Salloum8, Basel Masri9 and Thurayya Arayssi10, 1Rheumatology, Saint-Joseph University, Beirut, Lebanon, 2Rheumatology, King Hamad University Hospital, Bahrain, Bahrain, 3Rheumatology, King Hussein Medical Center, Royal Medical Services, Amman, Jordan, 4Rheumatology, Specialized Medical Center, Riyadh, Saudi Arabia, 5Rheumatology, Cairo University, Cairo, Egypt, 6Dr. Humeira Badsha Medical Center, Dubai, United Arab Emirates, 7Medicine, Saint-Joseph University, Beirut, Lebanon, 8Registered Nurse, Beirut, Lebanon, 9Rheumatology, Jordan Hospital, Amman, Jordan, 10Medicine, Weill Cornell Medicine-Qatar, Doha, Qatar

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Education, patient, patient engagement, patient outcomes, rheumatoid arthritis (RA) and social media

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 23, 2018

Title: Patient Outcomes, Preferences, and Attitudes Poster II: Patient Perspectives

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:

Empowering RA patients through education is linked to improved adherence, treatment decisions and speeding up the assessment process during consultation. The purpose of the study is to evaluate perceptions of patients with RA about self-assessment of their disease activity after watching an educational video about self-assessment using Disease Activity Score 28 (DAS28).

Methods:

An educational video was developed to instruct patients with RA on how to assess their disease activity using DAS28 (autoDAS). Consecutive RA patients attending rheumatology clinics during their routine visits (Bahrain, Egypt, Jordan, Lebanon, KSA, UAE) were invited to participate in a structured interview with the study coordinator after the doctor’s visit. A purposely-designed video was displayed first, followed by the interview that consisted of a combination of closed and qualitative open-end questions.

Results:

62 patients participated in the study (Fig1). 95% stated that performing their own assessment was feasible or partially feasible, and 97% said that they felt totally or partially capable of doing it. 59% answered that they felt confident in performing auto-DAS all the times. Nevertheless, 76% stated that it will not replace the doctor’s visit. The majority (96%) felt that the video was easy and helpful in facilitating their self-assessment (Fig2).

Open-end questions identified the main advantages: Better understanding of the disease (“makes me aware when disease is active, provides good education about disease, will help me cope better”), Easier communication with physician (“will inform me about the joint I need to tell my doctor about”), Time management (“Less time with physician, less visits meaning less cost”). They also identified some challenges: Calculation was cumbersome (with the calculator being easier than a website), Auto-assessment needs practice.

Conclusion:

The majority of patients felt that the video was helpful in many aspects of disease assessment, and felt capable of performing auto-evaluation, with DAS calculation being the hardest part. Most stated that it will not replace the doctor’s visit but will help better understanding of the disease and coping, thus better informing the doctor and reducing visit time.

Figure 1. Patients Characteristics

Patients, N

62

Age, mean

51.2 yo (SD 13.4)

Female

86%

University education

40%

RA duration, mean

9.3 years (SD 6.6)

Time to diagnosis, mean

1.9 years (SD 6.4)

Rheumatoid Factor +

67%

ACPA +

46%

Bone erosions

48%

Biologic treatment

32%

Targeted Synthetic DMARD

11%

Corticosteroids

24%

Common Comorbidities

Smoking 19%, Hypertension 13%, Osteoporosis 13%, Dyslipidemia 11%, Diabetes 11%, Fibromyalgia 6%

Figure 2. RA patients’ responses to some questions of the structured interview.


Disclosure: N. Ziade, None; S. Saad, None; M. al Mashaleh, None; L. el Kibbi, None; B. el Zorkany, None; H. Badsha, None; G. Harifi, None; A. Daher, None; N. Salloum, None; B. Masri, None; T. Arayssi, None.

To cite this abstract in AMA style:

Ziade N, Saad S, al Mashaleh M, el Kibbi L, el Zorkany B, Badsha H, Harifi G, Daher A, Salloum N, Masri B, Arayssi T. Perceptions of Patients with Rheumatoid Arthritis about Self-Assessment of Disease Activity after Watching an Educational Video: Qualitative Pilot Results from the Auto-DAS in Middle Eastern Arab Countries Study [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/perceptions-of-patients-with-rheumatoid-arthritis-about-self-assessment-of-disease-activity-after-watching-an-educational-video-qualitative-pilot-results-from-the-auto-das-in-middle-eastern-arab-coun/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/perceptions-of-patients-with-rheumatoid-arthritis-about-self-assessment-of-disease-activity-after-watching-an-educational-video-qualitative-pilot-results-from-the-auto-das-in-middle-eastern-arab-coun/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology